Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,027 public trials 1,169 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Active, Not Recruiting

MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

NCT02352883

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +7 more
Locations
  • Kaiser Permanente-San Diego Zion San Diego, California, United States
  • Kaiser Permanente-San Marcos San Marcos, California, United States
  • Greenwich Hospital Greenwich, Connecticut, United States
  • Hartford Hospital Hartford, Connecticut, United States
View all 76 locations
View Trial Details
Active, Not Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

NCT04198766

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +56 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles Cancer Network Glendale, California, United States
  • California Research Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

A Study of Belzutifan (MK-6482) as Monotherapy and in Combination With Lenvatinib (E7080/MK-7902) With or Without Pembrolizumab (MK-3475) in China Participants With Advanced Renal Cell Carcinoma (MK-6482-010)

NCT05030506

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Beijing Cancer hospital-Digestive Oncology ( Site 0001) Beijing, Beijing Municipality, China
  • SUN YAT-SEN UNIVERSITY CANCER CENTRE-Urology Surgery Department ( Site 0005) Guangzhou, Guangdong, China
  • Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S Nanjing, Jiangsu, China
  • Tianjin Medical University Cancer Institute and Hospital ( Site 0003) Tianjin, Tianjin Municipality, China
View Trial Details
Active, Not Recruiting

Neuroendocrine Tumors - Patient Reported Outcomes

NCT05064150

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of Kansas Medical Center Research Institute, Inc Kansas City, Kansas, United States
  • Regents of the University of Michigan Ann Arbor, Michigan, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

NCT05879822

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +36 more
Locations
  • Fundacao Pio Xii Hospital de Cancer de Barretos Barretos, Brazil
  • Cionc-Centro Integrado de Oncologia de Curitiba Curitiba, Brazil
  • Hospital Erasto Gaertner - Liga Paranaense de Combate Ao Câncer Curitiba, Brazil
  • Oncosite - Centro de Pesquisa Clinica E Oncologia Ijuí, Brazil
View all 54 locations
View Trial Details
Active, Not Recruiting

Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy

NCT03755791

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Exelixis Clinical Site #208 Phoenix, Arizona, United States
  • Exelixis Clinical Site #159 Tucson, Arizona, United States
  • Exelixis Clinical Site #44 La Jolla, California, United States
  • Exelixis Clinical Site #112 Los Angeles, California, United States
View all 245 locations
View Trial Details

Related conditions